These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 29665276)
1. Engineered Hsp Protein Nanocages for siRNA Delivery. Guan X; Chang Y; Sun J; Song J; Xie Y Macromol Biosci; 2018 May; 18(5):e1800013. PubMed ID: 29665276 [TBL] [Abstract][Full Text] [Related]
2. Bioengineered Protein Nanocage by Small Heat Shock Proteins Delivering mTERT siRNA for Enhanced Colorectal Cancer Suppression. Wang H; Liu N; Yang F; Hu N; Wang M; Cui M; Bruns N; Guan X ACS Appl Bio Mater; 2022 Mar; 5(3):1330-1340. PubMed ID: 35234441 [TBL] [Abstract][Full Text] [Related]
3. EGFP-Based Protein Nanoparticles with Cell-Penetrating Peptide for Efficient siRNA Delivery. Guan X; Hu X; Cui F; Li Y; Jing X; Xie Z Macromol Biosci; 2015 Nov; 15(11):1484-9. PubMed ID: 26109167 [TBL] [Abstract][Full Text] [Related]
4. Dendrimer Nanovectors for SiRNA Delivery. Liu X; Peng L Methods Mol Biol; 2016; 1364():127-42. PubMed ID: 26472447 [TBL] [Abstract][Full Text] [Related]
5. Chitosan Nanoparticles for SiRNA Delivery In Vitro. Ragelle H; Vanvarenberg K; Vandermeulen G; Préat V Methods Mol Biol; 2016; 1364():143-50. PubMed ID: 26472448 [TBL] [Abstract][Full Text] [Related]
7. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes. Choi KM; Jang M; Kim JH; Ahn HJ Biomaterials; 2014 Aug; 35(25):7121-32. PubMed ID: 24854094 [TBL] [Abstract][Full Text] [Related]
8. Glycerol monooleate-based nanocarriers for siRNA delivery in vitro. Zhen G; Hinton TM; Muir BW; Shi S; Tizard M; McLean KM; Hartley PG; Gunatillake P Mol Pharm; 2012 Sep; 9(9):2450-7. PubMed ID: 22794355 [TBL] [Abstract][Full Text] [Related]
9. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy. Ku SH; Kim K; Choi K; Kim SH; Kwon IC Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of osteoclastogenesis through siRNA delivery with tunable mesoporous bioactive nanocarriers. Kim TH; Singh RK; Kang MS; Kim JH; Kim HW Acta Biomater; 2016 Jan; 29():352-364. PubMed ID: 26432439 [TBL] [Abstract][Full Text] [Related]
11. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin. Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896 [TBL] [Abstract][Full Text] [Related]
12. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System. Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841 [TBL] [Abstract][Full Text] [Related]
13. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery. Wang XL; Xu R; Lu ZR J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104 [TBL] [Abstract][Full Text] [Related]
14. Triblock copolymer-encapsulated nanoparticles with outstanding colloidal stability for siRNA delivery. Qian J; Gao X ACS Appl Mater Interfaces; 2013 Apr; 5(8):2845-52. PubMed ID: 23320382 [TBL] [Abstract][Full Text] [Related]